Publications by authors named "Jan Brabender"

Claim this Profile
P
Prognostic impact of blood biomarkers TS and DPD in neoadjuvant-treated esophageal cancer patients.
Peter P Grimminger, Martin K H Maus, Juliane Bergenthal, Christoph Wandhöfer, Ullrich K Fetzner, Jan Brabender

Anticancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The G protein Gα11 is essential for hypertrophic signalling in diabetic myocardium.
Hannes Reuter, Katharina Seuthe, Yüksel Korkmaz, Sabine Grönke, Dieter Paul Hoyer, Jan Brabender

Int J Cardiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC.
Peter P Grimminger, Martin K H Maus, Paul M Schneider, Ralf Metzger, Arnulf H Hölscher, Jan Brabender

Lung Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of thymidylate synthase and dihydropyrimidine dehydrogenase expression in blood as predictors of response to multimodal therapy in esophageal cancer.
Jan Brabender, Ralf Metzger, Daniel Vallböhmer, Frederike Ling, Susanne Neiss

Surgery· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: ERCC1 gene polymorphisms for prediction of response and prognosis.
Ralf Metzger, Ute Warnecke-Eberz, Hakan Alakus, Fabian Kütting, Jan Brabender

J Gastrointest Surg· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis.
Uta Drebber, Martin Madeja, Margarete Odenthal, Inga Wedemeyer, Stefan P Mönig, Jan Brabender

Int J Colorectal Dis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting response to neoadjuvant therapy in esophageal cancer.
Daniel Vallböhmer, Jan Brabender, Peter Grimminger, Wolfgang Schröder, Arnulf H Hölscher

Expert Rev Anticancer Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
Uta Drebber, Max Lay, Inga Wedemeyer, Daniel Vallböhmer, Elfriede Bollschweiler, Jan Brabender

Int J Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer.
Peter P Grimminger, Jan Stöhlmacher, Daniel Vallböhmer, Paul M Schneider, Arnulf H Hölscher, Jan Brabender

J Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of quality indicators following implementation of total mesorectal excision in primarily resected rectal cancer changed future management.
Paul M Schneider, Daniel Vallbohmer, Yvonne Ploenes, Georg Lurje, Ralf Metzger, Jan Brabender

Int J Colorectal Dis· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer.
Kosuke Narumiya, Ralf Metzger, Elfriede Bollschweiler, Hakan Alakus, Jan Brabender

Pharmacogenomics· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XRCC1 gene polymorphism for prediction of response and prognosis in the multimodality therapy of patients with locally advanced rectal cancer.
Peter P Grimminger, Jan Brabender, Ute Warnecke-Eberz, Kosuke Narumiya, Christoph Wandhöfer

J Surg Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC).
Peter P Grimminger, Paul M Schneider, Ralf Metzger, Daniel Vallböhmer, Kathleen D Danenberg, Jan Brabender

Lung Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer.
Peter P Grimminger, Paul M Schneider, Ralf Metzger, Daniel Vallböhmer, Arnulf H Hölscher, Jan Brabender

Clin Lung Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer.
Peter P Grimminger, Paul M Schneider, Ralf Metzger, Daniel Vallböhmer, Kathleen D Danenberg, Jan Brabender

Clin Lung Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma.
Andreas-Claudius Hoffmann, Daniel Vallböhmer, Peter Grimminger, Ralf Metzger, Klaus L Prenzel, Jan Brabender

Pharmacogenomics· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors.
Daniel Vallböhmer, Jan Brabender, Ralf Metzger, Arnulf H Hölscher

J Gastrointest Surg· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of survivin RNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer.
Peter Grimminger, Daniel Vallböhmer, Andreas Hoffmann, Christian Schulte, Elfriede Bollschweiler, Jan Brabender

J Surg Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic therapy for esophageal perforation or anastomotic leak with a self-expandable metallic stent.
Jessica M Leers, Carlo Vivaldi, Hartmut Schäfer, Marc Bludau, Jan Brabender

Surg Endosc· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome.
Andreas-Claudius Hoffmann, Daniel Vallböhmer, Klaus Prenzel, Ralf Metzger, Michaela Heitmann, Jan Brabender

J Cancer Res Clin Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
Jan Brabender, Dariusch Arbab, Xi Huan, Daniel Vallböhmer, Peter Grimminger

Ann Surg Oncol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection.
Andreas-Claudius Hoffmann, Jan Brabender, Ralf Metzger, Fredericke Ling, Ute Warnecke-Eberz

J Surg Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Ralf Metzger, Daniel Vallbohmer, Carsten Müller-Tidow, Hiroshi Higashi, Elfriede Bollschweiler, Jan Brabender

Anticancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the homeobox genes BFT and CDX2 in the pathogenesis of non-small cell lung cancer.
Peter Grimminger, Frederike C Ling, Susanne Neiss, Daniel Vallböhmer, Georg Lurje, Jan Brabender

Anticancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer.
Paul M Schneider, Ralf Metzger, Hartmut Schaefer, Frank Baumgarten, Daniel Vallbohmer, Jan Brabender

Ann Surg· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis